Search research articles
Contact Us
Filters
Showing results (451-460 of 610) with videos related to
Page
of 61
Sort By:
British Journal of Haematology
|
May 20, 2003
A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression
Francis J Giles, B Nebiyou Bekele, Susan O'Brien, et al.
Nature Communications
|
April 13, 2019
Hybrid longitudinal-transverse phonon polaritons
Christopher R Gubbin, Rodrigo Berte, Michael A Meeker, et al.
Journal of Pediatric Hematology/Oncology
|
December 8, 2011
Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model
Sachiko Ohshima-Hosoyama, Monika A Davare, Suresh I Prajapati, et al.
British Journal of Haematology
|
September 1, 1993
Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia
E N McSweeney, F J Giles, C P Worman, et al.
Blood
|
July 16, 2010
Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy
Hagop M Kantarjian, Francis J Giles, Peter L Greenberg, et al.
Cancer
|
March 26, 2004
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia
Francis J Giles, Martin S Tallman, Guillermo Garcia-Manero, et al.
Experimental Gerontology
|
July 28, 2009
Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification
Dominick G A Burton, Peter J Giles, Angela N P Sheerin, et al.
Leukemia Research
|
March 21, 2006
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease
Maher Albitar, Julie M Vose, Marcella M Johnson, et al.
Nature Chemistry
|
June 29, 2021
Mechanism of molybdate insertion into pterin-based molybdenum cofactors
Corinna Probst, Jing Yang, Joern Krausze, et al.
Leukemia Research
|
June 15, 2007
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia
Francis J Giles, Alan F List, Michael Carroll, et al.
Page
of 61
Search research articles
Search
Showing results (451-460 of 610) with videos related to
Sort By:
Page
of 61
British Journal of Haematology
|
May 20, 2003
A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression
Francis J Giles, B Nebiyou Bekele, Susan O'Brien, et al.
Nature Communications
|
April 13, 2019
Hybrid longitudinal-transverse phonon polaritons
Christopher R Gubbin, Rodrigo Berte, Michael A Meeker, et al.
Journal of Pediatric Hematology/Oncology
|
December 8, 2011
Preclinical testing of tandutinib in a transgenic medulloblastoma mouse model
Sachiko Ohshima-Hosoyama, Monika A Davare, Suresh I Prajapati, et al.
British Journal of Haematology
|
September 1, 1993
Recombinant interferon alfa 2a in the treatment of patients with early stage B chronic lymphocytic leukaemia
E N McSweeney, F J Giles, C P Worman, et al.
Blood
|
July 16, 2010
Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy
Hagop M Kantarjian, Francis J Giles, Peter L Greenberg, et al.
Cancer
|
March 26, 2004
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia
Francis J Giles, Martin S Tallman, Guillermo Garcia-Manero, et al.
Experimental Gerontology
|
July 28, 2009
Microarray analysis of senescent vascular smooth muscle cells: A link to atherosclerosis and vascular calcification
Dominick G A Burton, Peter J Giles, Angela N P Sheerin, et al.
Leukemia Research
|
March 21, 2006
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease
Maher Albitar, Julie M Vose, Marcella M Johnson, et al.
Nature Chemistry
|
June 29, 2021
Mechanism of molybdate insertion into pterin-based molybdenum cofactors
Corinna Probst, Jing Yang, Joern Krausze, et al.
Leukemia Research
|
June 15, 2007
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia
Francis J Giles, Alan F List, Michael Carroll, et al.
Page
of 61